Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Planning and monitoring of equivalence studies.

Durrleman S, Simon R.

Biometrics. 1990 Jun;46(2):329-36. Review.

PMID:
2194579
2.

[Methodological and statistical aspects of equivalence and non inferiority trials].

Elie C, De Rycke Y, Jais JP, Marion-Gallois R, Landais P.

Rev Epidemiol Sante Publique. 2008 Aug;56(4):267-77. doi: 10.1016/j.respe.2008.05.027. Epub 2008 Aug 13. Review. French.

PMID:
18703296
3.

Methodology of superiority vs. equivalence trials and non-inferiority trials.

Christensen E.

J Hepatol. 2007 May;46(5):947-54. Epub 2007 Mar 9. Review.

PMID:
17412447
4.

Methodological standards for assessing therapeutic equivalence.

Kirshner B.

J Clin Epidemiol. 1991;44(8):839-49. Review.

PMID:
1941037
5.

[The concept of therapeutic equivalence].

Lange S, Windeler J.

Med Klin (Munich). 1997 Apr 15;92(4):215-20. Review. German.

PMID:
9221304
6.

[The importance of equivalence trials in showing the usefulness of treatments].

Hermens ML, van Hout HP, Terluin B, Adèr HJ, de Haan M.

Ned Tijdschr Geneeskd. 2003 Nov 1;147(44):2162-6. Review. Dutch.

PMID:
14626832
7.

Issues in planning and interpreting active control equivalence studies.

Makuch R, Johnson M.

J Clin Epidemiol. 1989;42(6):503-11. Review.

PMID:
2661729
8.

Choice of delta: requirements and reality--results of a systematic review.

Lange S, Freitag G.

Biom J. 2005 Feb;47(1):12-27; discussion 99-107. Review.

PMID:
16395993
9.

[Equivalence studies in cardiovascular diseases].

Barbieri P, Marubini E.

Ital Heart J Suppl. 2004 Apr;5(4):267-75. Review. Italian.

PMID:
15346693
10.

Sequential methods and group sequential designs for comparative clinical trials.

Sébille V, Bellissant E.

Fundam Clin Pharmacol. 2003 Oct;17(5):505-16. Review.

PMID:
14703713
11.

Equivalence approaches.

Williams RL, Chen ML, Hauck WW.

Clin Pharmacol Ther. 2002 Sep;72(3):229-37. Review. No abstract available.

PMID:
12235443
13.

Clinical equivalence.

Bristol DR.

J Biopharm Stat. 1999 Nov;9(4):549-61. Review.

PMID:
10576403
14.

Evaluating "superiority", "equivalence" and "non-inferiority" in clinical trials.

Turan FN, Senocak M.

Ann Saudi Med. 2007 Jul-Aug;27(4):284-8. Review.

PMID:
17684429
15.

Design of biological equivalence programs for therapeutic biotechnology products in clinical development: a perspective.

Mordenti J, Cavagnaro JA, Green JD.

Pharm Res. 1996 Oct;13(10):1427-37. Review.

PMID:
8899831
16.

Longitudinal data analysis (repeated measures) in clinical trials.

Albert PS.

Stat Med. 1999 Jul 15;18(13):1707-32. Review.

PMID:
10407239
17.

Establishing equivalence or non-inferiority in clinical trials: part 20 of a series on evaluation of scientific publications.

Wellek S, Blettner M.

Dtsch Arztebl Int. 2012 Oct;109(41):674-9. doi: 10.3238/arztebl.2012.0674. Epub 2012 Oct 12. Review.

18.

Sample size calculations for risk equivalence testing in pharmacoepidemiology.

Tubert-Bitter P, Manfredi R, Lellouch J, Bégaud B.

J Clin Epidemiol. 2000 Dec;53(12):1268-74. Review.

PMID:
11146274
19.

Treatment allocation methods in clinical trials: a review.

Kalish LA, Begg CB.

Stat Med. 1985 Apr-Jun;4(2):129-44. Review.

PMID:
3895341
20.

A perspective on the regulation of the evaluation of new antithrombotic drugs.

Califf RM.

Am J Cardiol. 1998 Oct 22;82(8B):25P-35P. Review.

PMID:
9809889
Items per page

Supplemental Content

Write to the Help Desk